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Abstract
Formation of the postsynaptic membrane at the skeletal neuromuscular junction (NMJ) requires activation of the muscle-specific
receptor tyrosine kinase (MuSK). Few intracellular mediators or modulators of MuSK actions are known. E3 ubiquitin ligases may serve
this role, because activities of several receptor tyrosine kinases, G-protein-coupled receptors and channels are modulated by
ubiquitination. Here, we report identification of a putative Ariadne-like ubiquitin ligase (PAUL) that binds to the cytoplasmic domain of
MuSK. PAUL is expressed in numerous tissues of developing and adult mice, and is present at NMJs in muscle fibers but is not
confined to them.
q 2003 Elsevier B.V. All rights reserved.
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Much of what is known about the mechanisms of synaptic
development comes from the study of the vertebrate
neuromuscular junction (NMJ) (Sanes and Lichtman,
1999). A well-studied aspect of this process is the clustering
of acetylcholine receptors (AChRs) in the postsynaptic
membrane. AChR clustering is promoted and/or stabilized
by the presynaptic protein agrin; agrin, in turn, signals by
activating the muscle specific receptor tyrosine kinase
(MuSK) (McMahan, 1990; Glass et al., 1996; Sanes and
Lichtman, 2001). Little is known, however, about how
activation of MuSK leads to AChR clusters, or how MuSK
levels and activity are regulated.
An intriguing system in this regard is E3-dependent
ubiquitination, which has recently been shown to serve as a
regulatory mechanism for signaling and trafficking of
several receptors. For example, the adaptor protein Cbl
has been shown to ubiquitinate and thereby regulate
receptor tyrosine kinase signaling through its E3 activity
(Pride et al., 2002). In addition, barrestin-dependent
ubiquitination by an E3, Mdm2, attenuates adrenergic
receptor signaling (Shenoy et al., 2001). Related mechan-
isms may be involved in neuromuscular development.
Indeed, AChR trafficking in cultured myotubes is affected
by ubiquitination (Keller et al., 2001) and ubiquitin ligases
play key roles in muscle growth and atrophy (Glass, 2003).
Moreover, the ubiquitin pathway has recently been shown to
regulate NMJ development in Drosophila (DiAntonio et al.,
2000; Hegde and DiAntonio, 2002) and synaptic compo-
sition at mammalian synapses (Ehlers, 2003). These data
raise the possibility that E3 ubiquitin ligases could play a
role in MuSK signaling and regulation of neuromuscular
development in vertebrates. Consistent with this idea, we
have found, and describe here, a putative Ariadne-like
ubiquitin ligase that binds directly to MuSK.
1. Results and discussion
1.1. Identification and structure of PAUL
To identify components of the MuSK signaling pathway,
we employed the yeast two-hybrid system, using the
cytoplasmic domain of MuSK as bait (Apel et al., 2000).
Of 61 positive clones obtained from an E17 mouse cDNA
library, 12 encoded an 875 aa fragment of a novel protein;
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a 13th encoded an overlapping fragment of the same protein.
Rapid amplification of cDNA ends (RACE) was used to
obtain additional sequence, leading to assembly of a 3.8 kb
sequence that encoded a single 1067 aa open reading frame
(Fig. 1a), along with 30 and 50 UTR (Genbank accession
number AY283085).
Analysis of the deduced amino acid sequence showed that
it contains, from amino- to carboxy-terminal, a cysteine-rich
zinc finger (BBOX) a serine-rich region, a Ran binding-
protein zinc finger domain (zf-RanBP), an ubiquitin
association (UBA) domain, a Really Interesting New Gene
(RING) domain, an In-Between RING (IBR) domain, and a
second RING domain (Fig. 1a). Both BBOX and zf-RanBP
domains are believed to be involved in mediating protein–
protein interactions. RING and IBR domains are most often
found in a large and diverse family of E3 ubiquitin ligases,
Fig. 1. Primary sequence of PAUL and comparison with related proteins. (a) Deduced amino acid sequence of PAUL. Recognizable domains are underlined.
BBOX, B box domain; Ser-rich, serine-rich domain; zf-RanBP, Ran binding-protein zinc finger domain; UBA, UBA domain; RING, RING domain; IBR, IBR
domain. (b) Domain structure of mouse PAUL and its relationship to putative orthologues from human, Fugu and Drosophila. Figures at right indicate percent
amino acid sequence identity of the whole proteins with mouse PAUL; figures between lines indicate similarity of the RING1 and IBR domains. Arrowheads
labeled C13 and C74 indicate termini of two classes of clones isolated by yeast two-hybrid screening. (c,d) Relationship of RING1 and IBR domains of PAUL
with corresponding domains in other ariadne-like proteins that share the RBR signature (Marin and Ferrus, 2002). Human (h), fugu, and Drosophila
(d) orthologues are most similar to mouse (m) PAUL; more distant relatives are Ariadne-subfamily proteins and Parkin. Genbank accession numbers are in
Section 2.
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including Ariadne (see below), which catalyze the ligation
of activated ubiquitin to substrate proteins (Joazeiro and
Weissman, 2000). The UBA domain is found in several
proteins involved in ubiquitin signaling, including some E3
ubiquitin ligases (Hofmann and Bucher, 1996). Based on
these signature motifs, we call the novel protein Putative
Ariadne-like Ubiquitin Ligase or PAUL.
Searches of public and Celera databases identified a
human cDNA, FLJ10111, which is 86% identical to mouse
PAUL (Fig. 1b) (Yawata et al., 2001), but no other close
homologues in either mouse or human. We therefore believe
that FLJ10111 is human PAUL. It has been cytogenetically
mapped to chromosome 14 (14q11.2–q21.3). Further
searches revealed putative orthologues in Fugu (41%
amino acid identity to mouse PAUL) and Drosophila
(CG113211; 23% identity; Fig. 1b). We were unable to
identify close relatives of mouse or Drosophila PAUL in
C. elegans. We did find similarity to several proteins that
contain, like PAUL, a pair of RING domains separated by
an IBR domain. This arrangement, which has been called a
‘RBR signature’ (RING-Between RINGS-RING) has been
found in both demonstrated and Putative E3 ubiquitin
ligases (Marin and Ferrus, 2002). To determine the
relationship of PAUL to other RBR proteins, we compared
their RING1 and IBR domains. As shown in Fig. 1c and d,
PAUL is most similar to Ariadne, which binds E2 ubiquitin
conjugating enzymes (Ardley et al., 2001), and is also
closely related to Parkin, which has been shown to function
as an E3 ubiquitin ligase (Zhang et al., 2000). These
relationships strengthen the argument that PAUL is an E3
ubiquitin ligase.
1.2. Interaction of PAUL and MuSK
PAUL was isolated by virtue of its interaction with the
cytoplasmic domain of MuSK in the yeast two-hybrid assay.
Further assays in yeast showed that PAUL bound to a
fragment containing the carboxy-terminal 140 aa of
MuSK’s ,350 aa-long cytoplasmic domain, indicating
that the amino-terminal 210 aa were dispensable for this
interaction (data not shown). Interacting PAUL cDNA C13
showed that its RING and IBR domains were dispensable
for interaction with MuSK (Fig. 1b). Thus, sites in the
amino-terminal portion of PAUL bind sites in the carboxy-
terminal portion of the MuSK cytoplasmic domain.
Association of MuSK and PAUL in the cytoplasm of
mammalian cells was demonstrated by co-transfecting
cDNAs encoding epitope-tagged derivatives of both pro-
teins into a human embryonic kidney (HEK-293-T) cell
line, immunoprecipitating with an antibody to one member
of the pair, and immunoblotting the resulting complexes
with an antibody to the other member of the pair. Following
transfection with myc-PAUL and GFP-MuSK, immunopre-
cipitates collected with anti-myc contained GFP-MuSK; no
GFP-MuSK was present in control precipitates (Fig. 2a).
Likewise, following transfection with FLAG-tagged MuSK
and PAUL, immunoprecipitates collected with anti-FLAG
contained PAUL (data not shown).
To examine the consequences of MuSK-PAUL inter-
action on their localization, we stained HEK-293-T cells
following transfection with myc-PAUL and/or GFP-MuSK.
MuSK was localized to the membrane and to small,
intracellular, presumably vesicular puncta (Fig. 2b). In
contrast, in cells transfected with myc-PAUL alone,
PAUL was present throughout the cytoplasm (Fig. 2c).
Fig. 2. Association of PAUL andMuSK in transfected cells. (a) HEK-293-T
cells were transfected with myc-PAUL, GFP-MuSK, or both, as indicated.
Myc-PAUL was immunoprecipitated from cell lysates using myc antibody
(9E10), then precipitates were resolved by electrophoresis and probed with
anti-MuSK. GFP-MuSK is co-immunoprecipitated with myc-PAUL. (b–d)
HEK-293-T cells were transfected with GFP-MuSK (b,b0), myc-PAUL
(c,c0), or both (d,d0), then permeabilized and stained with anti-myc.
Coexpression of MuSK redistributes PAUL from the cytosol to MuSK-rich,
membrane-associated puncta. (e,e0) A mutant MuSK lacking almost the
entire cytoplasmic domain still localizes to puncta within the plasma
membrane, but fails to recruit PAUL to the membrane.
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Co-expression of both constructs had no apparent effect on
localization of MuSK, but led to redistribution of most of
the PAUL to MuSK-positive membrane-associated patches
(Fig. 2d). A similar redistribution of PAUL occurred when it
was co-expressed with a mutant of MuSK previously
demonstrated to lack kinase activity (MuSKK608A; Glass
et al., 1997; data not shown). In contrast, no redistribution of
PAUL occurred when it was co-expressed with a MuSK
mutant lacking its cytoplasmic domain (GFP-MuSKDcyto;
Zhou et al., 1999), even though the MuSK mutant itself
formed membrane-associated patches (Fig. 2e). These data
suggest that MuSK can recruit PAUL to the membrane.
1.3. Distribution of PAUL mRNA
We first used Northern blotting to assess expression of
PAUL. This analysis showed the presence of a,4 kb PAUL
RNA, consistent with the sequence assembled from cDNA
cloning. This RNA species was detected in all adult tissues
tested, including skeletal muscle and brain, although its
abundance varied among tissues (Fig. 3a). PAUL RNA was
also present in brain from a postnatal day (P) two mouse.
To localize sites of PAUL expression in embryonic
tissue, we used non-radioactive in situ hybridization. PAUL
was expressed in many tissues at embryonic day (E) 17, but
its level varied considerably among tissues (Fig. 4).
Particularly high levels of expression were detected in
the brain, liver, kidney and thymus (Figs. 4a,5a,g–i).
Expression was also detected in muscle, but the apparent
abundance of PAUL RNA was lower in muscles than in
many other organs, a pattern different from that observed in
adult tissues, as determined by Northern analysis.
Within the developing nervous system both progenitor
cells inproliferativezonesandpostmitoticcells inneuron-rich
layers expressed PAUL (Fig. 5b–d). These results raised the
possibility that PAUL is expressed in neurons. To address this
issue, we examined the distribution of PAUL RNA in adult
brain. Expression persisted in several neuronal population in
theadult,withnotablyhighlevels inthegranuleandpyramidal
cells of the hippocampus (Fig. 5e) and scattered neurons in
deep layers of the cerebral cortex (Fig. 5f).
1.4. Distribution and regulation of PAUL protein
To assay the distribution of PAUL protein, we generated
a rabbit antiserum to a recombinant fragment comprising
the carboxy-terminal half of PAUL. Immunoblotting of
cells transfected with a cDNA encoding full-length PAUL
showed that the resulting antibodies specifically recognized
a protein of ,135 kD (Fig. 3b); this size is consistent with,
though slightly larger than, that predicted from the cDNA
sequence. A protein of similar size was detected in all adult
tissues tested, with highest levels in brain and lung
(Fig. 3c). A second immunoreactive species of ,115 kD,
detected in brain and kidney may a represent smaller
isoform generated, for example, by alternative splicing.
However, because a similar band was present in cells
transfected with a single cDNA, we favor the idea that the
smaller band results from proteolytic degradation, either in
cells or during sample preparation.
To determine whether PAUL is developmentally regu-
lated, we compared levels of PAUL protein in tissues from
neonatal (P0) and adult tissues (Fig. 3d). In skeletal and
cardiac muscles, PAUL levels were several-fold higher at
P0 than in adults. In contrast, levels of PAUL in lung and
brain varied only a few-fold or less between neonates and
adults. Given the developmental decrease observed in
muscle, we also asked whether PAUL levels increased
following denervation, as has been reported for several
components of the postsynaptic membrane at the NMJ,
including AChRs and MuSK (Bowen et al., 1998; Sanes and
Lichtman, 1999). However, levels of PAUL in 3- or 10-day
denervated muscles were not significantly different than
those in control, innervated muscles (data not shown).
Finally, in view of the association of PAUL with MuSK
in vitro, we used two methods to ask whether PAUL is
Fig. 3. Detection and regulation of PAUL RNA and protein. (a) Northern
analysis of PAUL RNA. A 4 kb RNA is detectable in multiple adult mouse
tissues and in P2 mouse brain. (b) On immunoblots, antiserum to PAUL
specifically recognizes a 135 kD protein in PAUL-transfected QT6 cells.
(c) Western analysis of tissues from adult mice using anti-PAUL. A 135 kD
protein band is detectable in all tissues tested, with highest levels in lung
and brain. (d) Comparison of PAUL levels in P0 and adult tissues. PAUL
levels decrease in cardiac and skeletal muscle during postnatal develop-
ment. PAUL is barely detectable in cultured myotubes differentiated from
the myogenic C2C12 cell line.
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selectively associated with the postsynaptic apparatus. First,
sections of E18 muscles were doubly stained with anti-
PAUL plus rhodamine-labeled a-bungarotoxin, which
specifically labels the AChRs at synaptic sites. PAUL
immunoreactivity was detectable in myotubes, but not in the
connective tissue cells that separate fascicles of myotubes
(Fig. 6a,b). PAUL was present at bungarotoxin-labeled
synaptic sites, but was not confined to them (Fig. 6c,c0). In
adult muscle, PAUL levels were barely detectable, consist-
ent with Western blotting data (Fig. 3d), and again no
enrichment was observed at synaptic sites (data not shown).
Second, we stained C2C12 myotubes, in which AChRs form
distinct clusters following treatment with the nerve-derived
synaptic organizing molecule, agrin (Sanes and Lichtman,
1999). Because C2C12 cells express only low amounts of
PAUL (Fig. 3d), we transfected myoblasts with myc-tagged
PAUL before fusion to form myotubes, then stained
with anti-myc and rhodamine-labeled a-bungarotoxin.
As observed in vivo, PAUL was present throughout
the cytoplasm of the myotubes, in both receptor-rich and
receptor-poor areas, but it was not selectively localized to
areas of high receptor density (Fig. 6d).
2. Experimental procedures
2.1. Isolation and sequence analysis of paul
An E17 mouse cDNA library was screened using the
cytoplasmic domain of MuSK as bait. The screen was
performed in the HF7c yeast strain harboring HIS3 and
b-gal reporter genes under control of GAL4-binding sites.
Details of the screen were described previously (Apel et al.,
2000). PAUL cDNAs isolated from the library were
sequenced, and the sequence was extended by RACE
using poly(A)þ selected RNA from mouse adult brain.
Protein sequence motifs were detected using BLAST and
PFAM search engines.
Fig. 4. Expression of PAUL in the mouse embryo (a) Saggital section of an E17 mouse embryo. As assessed by in situ hybridization, expression of PAUL is
broad, but its abundance varies among tissues. (b) Adjacent section hybridized and stained in parallel with a control (sense) probe. br, brain; ht, heart; kid,
kidney; liv, liver; lu, lung; oe, olfactory epithelium.
P.A. Bromann et al. / Gene Expression Patterns 4 (2004) 77–84 81
Protein sequence alignments were performed using
MegAlign software (DNA Star). Genbank accession
numbers are as follows: mouse PAUL (AY283085),
human PAUL (NP_060469), Fugu PAUL (Scaffold_876),
Drosophila PAUL (AAF52435), human novel IBR protein
(CAB92088, C. elegans Ariadne-2 (Q22431), Drosophila
Ariadne-2 (NP_477374), mouse Ariadne-2 (NP_035920),
mouse Ariadne-1 (XP_134935), Drosophila Ariadne-1
(NP_523399), mouse Parkin (NP_057903), human ARA54
(NP_004281).
2.2. Generation of antibodies
A segment of mouse PAUL corresponding to the
carboxy-terminal 333 amino acids was expressed as a
glutathione-S-transferase (GST) fusion protein in bacteria.
Partially purified protein obtained by preparative gel
electrophoresis of bacterial inclusion bodies was used to
immunize rabbits.
2.3. RNA and protein analysis
For Northern analysis, poly(A)þ RNAwas prepared from
mouse tissues, fractionated on formaldehyde–agarose gels
and transferred to GeneScreen Plus membrane (Perkin
Elmer, Boston, MA). Blots were probed with 32P-labeled
PAUL cDNA probe (random primed DNA labeling kit;
Roche Molecular Biochemicals, Indianapolis, IN).
For protein analysis, tissues were ground in solubil-
ization buffer (PBS, 1% Triton X-100, 100 mM PMSF, and
protease inhibitor cocktail) and centrifuged at 13,000 g
for 30 min at 4 8C. Protein concentration of supernatants
was determined by BCA assay using BSA as standard,
and aliquots corresponding to 100 mg protein were resolved
by gel electrophoresis, transferred to nitrocellulose
Fig. 5. Distribution of PAUL RNA in neural and non-neural tissues (a) High power micrographs of sections from E17 and adult mice. Olfactory system at E17.
PAUL is expressed in cells of the olfactory epithelium (oe), olfactory bulb (ob), and rostralcortex (ctx), with high levels in mitral cells (mc) of the bulb. (b,c)
E17 retina shows labeling throughout the neuroblast (nbl) and nascent ganglion cell layers (gcl) ((c) shows nuclei, stained with DAPI, in same field as (b)). (d)
E17 brain showing expression in the cortical ventricular zone (vz), cortical plate (cp), striatum (str), and hippocampus (hi). (e) Adult hippocampus shows
persistent expression in signal in the dentate gyrus (dg) and stratum pyramidale (sp). (f) Adult cortex, showing scattered PAUL-positive cells. The pial surface
is at the top. (g) E17 neck, showing strong expression in submandibular gland (smg) and thymus. (h) E17 lung (lu) and liver (liv). (i) E17 kidney (kid) and gut
endothelia (arrows).
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membranes, and probed with anti-PAUL. For immunopre-
cipitation, HEK-293-T, quail fibroblast (QT6) or mouse
myogenic (C2C12) cells were obtained from ATCC,
transfected using Fugene6 reagent (Roche), then harvested
one day later. Cells were lysed in solubilization buffer (PBS,
1% Triton X-100, 1% BSA, 1 mM iodoacetamide, 1 mM
PMSF, and protease inhibitor cocktail). Cell extracts were
centrifuged at 13,000 g at 4 8C for 30 min, and then
supernatants were subjected to immunoprecipitation with
antibodies to c-myc (9E10) or anti-FLAG epitope tag (M2,
Sigma, St Louis, MO). Complexes were isolated by binding
to protein G-Sepharose (Amersham Biosciences, Piscat-
away, NJ) and resolved by electrophoresis and
immunoblotting.
2.4. Histology
Tissues were fixed in PBS-buffered 4% paraformalde-
hyde (PFA), dissected, infiltrated with sucrose, frozen, and
sectioned in a cryostat at 8 mm. Sections were incubated
with anti-PAUL in blocking buffer (PBS, 4% BSA, 0.1%
Triton X-100), then washed extensively with PBS and
incubated for 1 h at room temperature with a mixture of
rhodamine-labeled a-bungarotoxin and Alexa-488 conju-
gated anti-rabbit IgG. HEK-293-T or C2C12 cells were
fixed for 20 min at room temperature with PBS-buffered
2% PFA, then stained as above. C2C12 cells were
maintained in fusion medium (DMEM plus 2% horse
serum) for 5 days to form multinucleated myotubes prior to
staining.
In situ hybridization was performed using digoxigenin-
labeled riboprobes, as described by Yin et al. (2002).
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Fig. 6. Cellular distribution of PAUL in skeletal myotubes. (a–c) Cryostat sections of E18 mice were stained with anti-PAUL (a and c) or preimmune rabbit
serum (b). The section in (c) was counterstained with bungarotoxin to label synaptic sites (c0). Skeletal myotubes are labeled by anti-PAUL; immunoreactivity
is present at synaptic sites but is not concentrated at them. (d,d0) C2C12 myotube transfected with myc-PAUL, then labeled with anti-myc and bungarotoxin. As
in vivo, PAUL is present but not concentrated in receptor-rich areas.
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